Pune, Oct. 10, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Biomaterials Market is expected to clock US$ 395.38 billion by 2030 and to grow at a CAGR of 13.7% during the forecast period. Biomaterials emerge as a promising option in various applications, especially cardiovascular, orthopedic, and orthodontics disorders, and boosting the market. This exclusive information is published by Growth Plus Reports in its report titled “Biomaterials Market – Global Outlook & Forecast 2022-2030”
Biomaterials are used for various purposes in the healthcare domain. They can be found naturally or derived synthetically and coordinate with biological systems. The growing prevalence of chronic conditions and the rising geriatric population anticipate the growth of the biomaterial market. Thus, growing demands for biomaterials in society can be a significant impacting driver in the market.
Get a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/biomaterials-market/7857
Market Drivers
The global biomaterials market is growing significantly and is expected to experience a high jump in the forecast period. This growth can be attributed to rising funds/investments made by government bodies in the research and development (R&D) department with a broadening utilization scope. A further factor in the development of the market is the increased need for biomaterials due to the growing incidence of chronic ailments, including cardiovascular disorders, neurological diseases, and orthopedic problems. In addition, the market is expected to grow due to greater awareness of the benefits of biomaterials and an increase in the count of road accidents. The global market for biomaterials is also expanding at a high pace due to an aging population and enhancement in the healthcare infrastructure of developing countries.
The global biomaterials market has been analyzed from three perspectives: material type, application, and region.
Speak to our Analyst to Understand the Impact of COVID-19 on Your Business: https://growthplusreports.com/inquiry/speak-analyst/biomaterials-market/7857
Excerpts from ‘By Application Segmentation’
The applications in the biomaterial market have been segmented into:
- Cardiovascular
- Orthopedic
- Dental
- Plastic Surgery
- Wound Healing
- Neurological Disorders
- Tissue Engineering
- Ophthalmology
The orthopedic segment dominates the market with the largest revenue share. The rising prevalence of different orthopedic diseases such as osteoarthritis, osteoporosis, etc. contributes to the development of the segment. Furthermore, growing road traffic accidents fuel the market growth. Also, the ever-increasing demand for different biomaterials, such as metallic and ceramic materials, because of their biocompatibility properties that are quite suitable in the orthopedic segment, further fuels the market expansion. Additionally, the growing innovations and constant product launches in orthopedic implants provide momentum to market development.
Excerpts from ‘By Region Segmentation’
The biomaterial market has been segmented into:
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)
North America dominates the market with the largest revenue share. This growth is owed to increased government investments, growth in the geriatric population, and favorable reimbursement policies. Furthermore, the rise in the prevalence of cardiovascular and orthopedic disorders/illnesses and the large base of market players further accelerates the market expansion in this region. Europe holds the second highest revenue share in the market because of constant technological advancement and the rise in the demand for biomaterials.
The Asia Pacific (APAC) is considered the fastest growing segment of this market; this growth can be attributed to the growing aged population, developing healthcare infrastructure, and enhancing medical tourism.
Excerpts from ‘Competitive Landscape
Some of the prominent players operating in the global biomaterials market are
- Wright Medical Group N.V. (Stryker)
- Invibio Ltd
- Evonik Industries AG
- Covalon Technologies Ltd
- CRS Holdings LLC
- Noble Biomaterials Inc
- Zimmer Biomet Holdings Inc
- Victrex plc
- Berkeley Advanced Biomaterials Inc
- CoorsTek Inc
- Koninklijke DSM N.V
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trend (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints
- Opportunities
- GLOBAL BIOMATERIALS MARKET- ANALYSIS & FORECAST, BY MATERIAL TYPES
- Ceramic
- Polymer
- Metallic
- Natural
- GLOBAL BIOMATERIALS MARKET- ANALYSIS & FORECAST, BY APPLICATIONS
- Cardiovascular
- Orthopedic
- Dental
- Plastic Surgery
- Wound Healing
- Neurological disorders
- Tissue Engineering
- Ophthalmology
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Directly Purchase Premium Copy of Biomaterials Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=LLZw7qyh1Lya00VDVXTNooVpxjig7IKwyVdpAL6e&report_id=7857&license=Single
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
